Resources
The latest in cell & gene research, from advanced therapies through to the latest developments in cell & gene research, therapies & manufacturing
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Cell & Gene Therapy Manufacturing
Proactive Approaches to Cell Culture Media and Process Control Strategies
Merck invests $25 million in a Kansas cell culture media plant, aiming to meet rising demand for advanced therapeutics while aligning with sustainability goals.
Cell & Gene Therapy Manufacturing
In Conversation With… Sophie Mountcastle, Network Manager, Innovation Hubs for Gene Therapies
Here, we discuss the crucial role of a collaborative network for gene therapy development across the UK and some of the successes seen to date.
Cell & Gene Therapy Manufacturing
AppNote CBM Highthroughput AAV Viral Titering using Nano-Plate Based Digital PCR
Cell & Gene Therapy Manufacturing
Automated and Gentle Isolation of Single Cells for Efficient Cloning of hiPSCs
Cell & Gene Therapy Manufacturing
Exploring the Effects of Insulin on Viral Vectors Production in HEK293 Cells
Cell & Gene Therapy Manufacturing
Immune Cell-Mediated Killing of A549 Cancer Target Cells in Real-Time
Cell & Gene Therapy Manufacturing
How Current and New Technologies can Overcome Challenges in Adherent Scale-Up
Cell & Gene Therapy Manufacturing
Optimising CHO-K1 Fed-Batch Cell Culture Mediums for mAb Production
The Chinese Hamster Ovary (CHO) cell line is widely used to produce recombinant proteins due to its high growing capacity and productivity.
Cell & Gene Therapy Manufacturing
Innovative Financial Strategies in Gene Therapy: A Shift Towards Sustainable Access
Discover the key strategies and financial nuances of gene therapy like outcome-driven contracts, payment plans, and shared financial agreements
Cell & Gene Therapy Manufacturing
Sustainability in Cell Therapy Manufacture: Improving Process Efficiency for Cell Line Development
Improving process efficiency is a key approach to factor in when looking at how cell therapy manufacture can be made more sustainable.
Cell & Gene Therapy Manufacturing
CAR T-REX Aims to Bolster Anti-Tumoural Immune Response
An international European consortium has received a €2.7m grant to improve the safety and effectiveness of CAR-T cell therapies for solid tumours. If successful, the grant could massively improve treatment outcomes for patients.
Cell & Gene Therapy Manufacturing
Crossing the Pond: Key Considerations for Stateside Biotechs Looking to the UK and Europe
Among the challenges faced by US biotechs looking at setting up in Europe, regulatory and cultural differences are chief among them. However, the strong tradition of scientific research and high standard of medical care across the Atlantic makes it worth the effort.
Cell & Gene Therapy Manufacturing
Healthcare Data Platforms: Expert Tips on Integrating Digitalisation with Cell and Gene Manufacturing
Developers looking to integrate digitalisation approaches into their pipeline should ensure that they choose a sensible architecture, rather than simply automating for the sake of it.
Cell & Gene Therapy Manufacturing
Metabolic Modelling and Machine Learning Technologies in Cell and Gene Manufacturing
Integrating PAT into metabolic modelling can help optimise the product obtained from cell cultures, augmenting the manufacturing process.
Cell & Gene Therapy Manufacturing
Cell and Gene Manufacturing Approaches and Winning Strategies for Commercialisation and Scale-Up
With a host of factors to consider in cell and gene manufacture, upscaling is still no small task. However, as industry experience accumulates and new technologies arrive on the market, there are an increasing number of options for developers looking to get their therapeutic on the road to the clinic.
Cell & Gene Therapy Manufacturing
AI in Gene Therapy: How Could Machine Learning Approaches Reshape Therapeutic Development?
As more developers bring their cell and gene therapy products to industry regulators, the need to drive cost and process efficiencies is on track to keep growing. Across the board, AI and machine learning approaches have the potential to streamline many aspects of development.
Cell & Gene Therapy Manufacturing
Industry Insights Into the FDA's Plans for Revised Gene Therapy Approval Approaches
Some additional measures announced include the launch of the Cell and Gene Therapy Access Model, as well as the interpolation of RWE into trials and a potential move away from animal models in validating treatment efficacy.
Cell & Gene Therapy Manufacturing
Q &A with Shilpi Rajoria
An interview Shilpi Rajoria, Director QC Analytical Testing at Bristol Myers Squibb.
Cell & Gene Therapy Manufacturing
Overcoming the Challenges in Cell Therapy Manufacturing
Udayanath Aich, Director at Bristol Myers Squibb, leads a Discussion Group on leveraging advanced technologies and biologics to mitigate challenges.
Cell & Gene Therapy Manufacturing
Looking into the Crystal Ball: The Future of Disruptive Cell and Gene Therapy Manufacturing
What will the future hold for autologous cell and gene therapy manufacturing? Tigen Pharma SA, share their predictions on the prospect of disruptive innovation for the industry.
Cell & Gene Therapy Manufacturing
AAV Manufacturing Using Osmolality
New Data from the Cell and Gene Therapy Catapult shows improved yield, quality, and process efficiency for AAV manufacturing using osmolality.
Cell & Gene Therapy Manufacturing
In Conversation With...Ruth Faram, HigherSteaks
Dr. Faram is co-founder and Chief Scientific Officer at HigherSteaks, where she leads the company strategy and research focus for the Stem Cell, Bioprocess, Differentiation and Biomaterial teams.
Cell & Gene Therapy Manufacturing
In Conversation With Jenny Prange, Head of GMP Production, Chief Scientific Officer and Co-Founder of Muvon Therapeutics
The present and the future, key insights into the cell and gene therapy manufacturing space
Cell & Gene Therapy Manufacturing
Developing Meaningful Assays: Balancing Biological Significance and QC-Compatibility
Katrina Adlerz, Scientist at The University of Texas MD Anderson Cancer Center presents on developing meaningful biologic assays at the Cell Therapy Analytics Symposium 2022.
Cell & Gene Therapy Manufacturing
Gene Therapy Manufacturing
June's Discussion Group welcomed a panel of industry experts to debate manufacturing and standardisation challenges for the commercialisation of cell and gene therapies.
Cell & Gene Therapy Manufacturing
Bio-Techne: Genome Engineering Services for Cell Therapy Manufacturing
Cell & Gene Therapy Manufacturing
Streamlining Stem Cell Manufacturing
Oxford Global's Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our January Discussion Group addressing ‘Streamlining Stem Cell Manufacturing' was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market's growth, its priorities, future outlook, and challenges.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things cell & gene